Back to Market Feed

Product Information

DEXTROAMPH-AMPHET ER 12.5 MG CP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $8.4359 per EA under NDC 57664095088. Its NADAC has been published 124 times since May 22, 2024.

FDA first approved this application on Sep 27, 2023. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

NDC

57664095088

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215997

FDA Approved

9/27/2023

TE Code

AB2

On Market Since

2/1/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMPH-AMPHET ER 12.5 MG CP has been published 124 times since May 22, 2024, and over the history we have for it it has risen 7.3%. The table below summarizes its recorded NADAC range and movement.

Current price$8.4359 per EA
All-time high$8.8437 (Aug 13, 2025)
All-time low$7.8649 (May 22, 2024)
52-week high$8.6752
52-week low$8.0653
Median price$8.3525
Average price$8.3649
Largest weekly change+6.2% (Jun 19, 2024)
Weeks tracked124
Tracking sinceMay 22, 2024

Price History

1W

0.0%

1M

+2.1%

3M

+4.2%

6M

+0.9%

1Y

-2.8%

3Y

N/A

5Y

N/A

All

+7.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0422
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0622
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0622
per EA
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0648
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0648
per EA
PAIN RELIEVER PLS 250-250-65 MG
Generic
00536132601•Rugby Laboratories
$0.0648
per EA
MIGRAINE 250-250-65 MG CPLT
Generic
24385036571•AmerisourceBergen
$0.0648
per EA
MIGRAINE FORMULA CAPLET
Generic
24385036578•AmerisourceBergen
$0.0648
per EA

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Sun Pharmaceutical Industries Inc. manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Central Nervous System Stimulant class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of DEXTROAMPH-AMPHET ER 12.5 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPH-AMPHET ER 12.5 MG CP, manufactured by Sun Pharmaceutical Industries Inc., is $8.4359 per EA (NDC 57664095088), effective Sep 30, 2026.

How has the price of DEXTROAMPH-AMPHET ER 12.5 MG CP changed over time?

Over the history we have for it, the NADAC for DEXTROAMPH-AMPHET ER 12.5 MG CP has risen 7.3%. It has been tracked across 124 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for DEXTROAMPH-AMPHET ER 12.5 MG CP?

Since May 22, 2024, the NADAC for DEXTROAMPH-AMPHET ER 12.5 MG CP has ranged from a low of $7.8649 (May 22, 2024) to a high of $8.8437 (Aug 13, 2025), with a median of $8.3525 per EA.

Are there cheaper alternatives to DEXTROAMPH-AMPHET ER 12.5 MG CP?

No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPH-AMPHET ER 12.5 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMPH-AMPHET ER 12.5 MG CP?

DEXTROAMPH-AMPHET ER 12.5 MG CP (NDC 57664095088) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.